Priya Singhal

772 total citations · 1 hit paper
15 papers, 560 citations indexed

About

Priya Singhal is a scholar working on Pharmacology, Physiology and Epidemiology. According to data from OpenAlex, Priya Singhal has authored 15 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Priya Singhal's work include Alzheimer's disease research and treatments (2 papers), Multiple Sclerosis Research Studies (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Priya Singhal is often cited by papers focused on Alzheimer's disease research and treatments (2 papers), Multiple Sclerosis Research Studies (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Priya Singhal collaborates with scholars based in United States, Switzerland and India. Priya Singhal's co-authors include Karen Smirnakis, Stephen Salloway, Ying Tian, Spyros Chalkias, Samantha Budd Haeberlein, Patrick Burkett, Kimberly Umans, Guanfang Wang, Frederik Barkhof and Fiona Forrestal and has published in prestigious journals such as Neurology, Clinical Science and JAMA Neurology.

In The Last Decade

Priya Singhal

13 papers receiving 550 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

2021 411 citations Stephen Salloway, Spyros Chalkias et al. JAMA Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Priya Singhal United States	7	320	143	127	107	81	15	560
Antonio Páez Spain	14	369 1.2×	76 0.5×	174 1.4×	103 1.0×	112 1.4×	37	660
Patrick Burkett United States	2	280 0.9×	103 0.7×	97 0.8×	102 1.0×	74 0.9×	4	415
Kimberly Umans United States	7	301 0.9×	110 0.8×	107 0.8×	107 1.0×	85 1.0×	12	582
Françoise Gerber Switzerland	5	348 1.1×	122 0.9×	128 1.0×	83 0.8×	137 1.7×	7	556
Gregory D. Van Vickle United States	6	501 1.6×	94 0.7×	161 1.3×	133 1.2×	170 2.1×	6	608
Luc Bracoud United States	11	410 1.3×	149 1.0×	126 1.0×	128 1.2×	133 1.6×	42	679
Sangita P. Mehta United States	8	672 2.1×	93 0.7×	272 2.1×	296 2.8×	109 1.3×	11	797
Wang‐Sheng Jin China	10	292 0.9×	49 0.3×	135 1.1×	113 1.1×	103 1.3×	22	506
Ana‐Caroline Raulin United States	6	268 0.8×	41 0.3×	176 1.4×	61 0.6×	123 1.5×	8	514
Sue Griffin United States	9	237 0.7×	61 0.4×	216 1.7×	99 0.9×	52 0.6×	14	522

Countries citing papers authored by Priya Singhal

Since Specialization

Citations

This map shows the geographic impact of Priya Singhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priya Singhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priya Singhal more than expected).

Fields of papers citing papers by Priya Singhal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priya Singhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priya Singhal. The network helps show where Priya Singhal may publish in the future.

Co-authorship network of co-authors of Priya Singhal

This figure shows the co-authorship network connecting the top 25 collaborators of Priya Singhal. A scholar is included among the top collaborators of Priya Singhal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priya Singhal. Priya Singhal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Chen, Tianle, John O’Gorman, Carmen Castrillo‐Viguera, et al.. (2024). Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab. Alzheimer s & Dementia. 20(5). 3406–3415. 11 indexed citations

2.

Mazumder, Rupa, et al.. (2023). In Search of Novel SGLT2 Inhibitors by High-throughput Virtual Screening. Current Drug Discovery Technologies. 21(3). 20–31.

3.

Lyons, Jennifer, Nolan Campbell, George Kong, et al.. (2023). Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world. Expert Opinion on Drug Safety. 22(10). 995–1002. 5 indexed citations

4.

Lyons, Jennifer, et al.. (2022). Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(4). 5–25. 7 indexed citations

5.

Salloway, Stephen, Spyros Chalkias, Frederik Barkhof, et al.. (2021). Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease. JAMA Neurology. 79(1). 13–13. 411 indexed citations breakdown →

6.

Judson, Marc A., Brett M. Elicker, Thomas V. Colby, et al.. (2019). The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials. Respiratory Medicine. 149. 23–27. 6 indexed citations

7.

Hanna, Jerome, et al.. (2018). Clinical Trial and Post-marketing Reports Indicate No Increased Risk of Herpes Zoster in Patients Treated With Delayed-release Dimethyl Fumarate (P5.362). Neurology. 90(15_supplement). 2 indexed citations

8.

Singhal, Priya, et al.. (2015). Dentinogenesis Imperfecta Type II–A Case Report with Review of Literature. Journal of medical research/The journal of medical research. 14(4). 3 indexed citations

9.

Arya, Sugandha, et al.. (2015). Fibro-epithelial Polyp - Report of Two Cases with Literature Review. 1 indexed citations

10.

Hulse, Richard P., Nicholas Beazley‐Long, Nikita Ved, et al.. (2015). Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration. Clinical Science. 129(8). 741–756. 51 indexed citations

11.

Singhal, Priya, et al.. (2014). Riga fede disease: a case report. ANNALS AND ESSENCES OF DENTISTRY. 6(1). 19–19.

12.

Aggarwal, Priya, et al.. (2014). Study Habits of Higher Performing Engineering Students: A Survey. International Journal of Computer Applications. 97(2). 33–37. 4 indexed citations

13.

Roujeau, Jean‐Claude, Maja Mockenhaupt, Steven R. Tahan, et al.. (2012). Telaprevir-Related Dermatitis. JAMA Dermatology. 149(2). 152–152. 43 indexed citations

14.

Kidwai, Mazaahir, et al.. (2007). A Convenient K2CO3 Catalysed Regioselective Synthesis for Benzopyrano[4,3-c]pyrazoles in Aqueous Medium. Heterocycles. 71(3). 569–569. 14 indexed citations

15.

Kidwai, Mazaahir, et al.. (2007). One-Pot Heterocondensation for Benzoxazinone Derivatives Using Sodium Perborate as Catalyst. Heterocycles. 71(7). 1615–1615. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact